Three absurdly cheap dividend stocks that are trading at modest multiples of their expected earnings today are Merck (NYSE: ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

FOLD and EDIT are in the spotlight following patent dispute settlement news and strategic updates, respectively.

A 33-year-old man presented to our dermatology clinic with a 1-month history of two painless ulcers on his right arm and ...

The healthcare sector has been a focal point for investors in 2024, offering a compelling blend of innovation-driven ...

Amgen's move follows the lifting of a temporary injunction on the launch of its Pavblu-branded biosimilar by the US Court of ...

A new national research hub will position the UK as a world leader in the emerging global field of long-acting therapeutics ...

Almost a year after an appellate court judge revoked its previous permit, Harm Reduction Coalition of Santa Cruz County is ...

In moving the NHS from broken to “fixed” (doi:10.1136/bmj.q2309),1 the focus is on three shifts identified in the Darzi ...

But in March semaglutide (a GLP-1 receptor ... been mooted as a treatment for long-term infections, are being investigated ...

Authors Key Points Media Contact For general and media inquiries and to book our experts, please contact: [email protected] ...

Results showed treatment with Dupixent significantly reduced itch and urticaria ... added to standard-of-care histamine-1 (H1) antihistamines. At 24 weeks, Dupixent demonstrated significant ...